Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- (Z)-octadec-9-enoic-15,15,16,16,17,17,18,18,18-d9 acid
- Correlated keywords
- deuterated deuterium GCMS LCMS B 115 B115 C18:1 C18:1n9c Clear FRAC EF FRACEF Crodacid O-P OP Crossential O 94 O94 D-100 D100 Edenor ATiO5 18:1-98-100 FTiO5 Emersol 205 211 231NF 213-NF 214NF 214-NF 233 622 6313NF 6313-NF Extra Oleic 80R 90 99 Extra Olein 80 80R 90 90R 99 A-1981 A1981 Impex Industrene 105 Lubolic acid Lunac LO-V LOV OCA OLL OLLV OP OA OV NAA200 NAA200 35 36 38 NAA35 NAA36 NAA38 Neo-Fat 92-04 NeoFat 9204 Oleine 7503 Palmera A 1813 PalmeraA 1813 A1813 Pamolyn 100 PM 500 PM500 PM 810B PM810B POFAC 930 POFAC930 Priolene 6204 6906 6907 6928 6930 6933 Radiacid 0137 0212 Vopcolene 27 Wecoline OO TNF? IL8 IL6 IL1?
- Product Overview:
Oleic acid-d9 is intended for use as an internal standard for the quantification of oleic acid (Item Nos. 90260 | 24659) by GC- or LC-MS. Oleic acid is a monounsaturated fatty acid and a major component of membrane phospholipids that has been found in human plasma, cell membranes, and adipose tissue.{3964,42296} It contributes approximately 17% of the total fatty acids esterified to phosphatidylcholine, the major phospholipid class in porcine platelets.{3964} Oleic acid inhibits collagen-stimulated platelet aggregation by approximately 90% when used at a concentration of 10 µg/ml. It also inhibits fMLF-induced neutrophil aggregation and degranulation by 55 and 68%, respectively, when used at a concentration of 5 µM, similar to arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607).{2095} Oleic acid (60 µM) induces release of intracellular calcium in human platelets.{4198} In vivo, oleic acid increases TNF-?, IL-8, IL-6, and IL-1? production, neutrophil accumulation, and apoptotic and necrotic cell death in mouse lung and has been used to induce lung injury in a mouse model of acute respiratory distress syndrome (ARDS).{42296}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.